News|Artificial Intelligence| June 25, 2021

New technology helps doctors read mammograms faster, and with greater accuracy, which can reduce false positives for women

Breast cancer recently surpassed lung cancer as the number 1 diagnosed cancer in the U.S., excluding nonmelanoma skin cancer. Additionally, the National Cancer Institute recently predicted an almost 10,000 excess deaths from breast and colorectal cancers over the next 10 years as a direct result of the pandemic, making it now more important than ever for women to take control over their breast health.

June 25, 2021 — Breast cancer recentlysurpassedlung cancer as the number 1 diagnosed cancer in the U.S., excluding nonmelanoma skin cancer. Additionally, theNational Cancer Instituterecentlypredictedan almost 10,000 excess deaths from breast and colorectal cancers over the next 10 years as a direct result of the pandemic, making it now more important than ever for women to take control over their breast health. Recently,Randy Hicks, M.D., MBA, Co-Owner and CEO ofRegional Medical Imaging(RMI) in Michigan, participated in a nationwide satellite media tour to discuss how new technology is helping the fight againstbreast cancer.

TheCOVID-19pandemic brought routine health screenings, such as mammograms, to ascreeching halt, declining up to 92% in some areas last year, according to astudyin theJournal of the American College of Radiology. Now, with Americans getting vaccinated and infection rates decreasing around the country, many women are playing catch-up on these vital health screenings, which leads to another issue — a drastic increase in workload for doctors, who must face a surge of patients who need to be screened.

幸运的是,一种创新的新工具可用来帮助临床医生应对这种突然的需求,同时为他们提供了比以往任何时候都更高的准确性。ProFound AIuses the latest in deep-learning artificial intelligence (AI) and is clinicallyprovento help radiologists read mammograms more than 50% faster - and with more accuracy - while also reducing false positives and unnecessary callbacks, which can be stressful for women.

ProFound AI was the first 3D tomosynthesis software using AI to be cleared by the FDA. A video accompanying this announcement is available here:https://youtu.be/7nWf973J1ww.

For more information:icadmed.com

Related Content

SBI is pleased to invite all members and nonmembers to submit original abstracts for presentation at the upcoming SBI Breast Imaging Symposium
News|Radiology Education

August 9, 2022 — SBI is pleased to invite all members and nonmembers to submit original abstracts for presentation at ...

TimeAugust 11, 2022
arrow
The SpeedBird and Concorde device platforms are based on TransMed7’s patented Zero5 work element composed of a fused, single element constructed from 3 hypotubes, laser cut and welded to form articulable twin cutter blades at the end of a rotating open tube
News|Ultrasound Women's Health

August 10, 2022 — TransMed7, LLC announced that the first clinical cases of the final commercial production version of ...

TimeAugust 10, 2022
arrow
Portable digital radiography brought to remote locations in Nepal
Feature|Radiology Business| By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

TimeAugust 01, 2022
arrow
Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ceiling, a ceiling-mounted angiography system designed for a wide range of routine and advanced procedures in interventional radiology (IR) and cardiology
News|RSNA

July 29, 2022 — The Radiological Society of North America (RSNA), in collaboration with the American Society of ...

TimeJuly 29, 2022
arrow
for patients with multiple architectural distortion (AD) identified on digital breast tomosynthesis (DBT), biopsy of all areas may be warranted, given the variation of pathologic diagnoses across AD in individual patients
News|2022世界杯篮球预选赛赛程

2022年7月28日-根据ARRS的《美国x线学杂志》(AJR),对于具有多重结构的患者……

TimeJuly 28, 2022
arrow
The National Comprehensive Cancer Network (NCCN) has published new NCCN Guidelines for Patients: Breast Cancer Screening and Diagnosis to help people understand their personal risk for breast cancer, when they should begin screening, and how often to screen
News|Mammography

July 28, 2022 — The National Comprehensive Cancer Network (NCCN) has published new NCCN Guidelines for Patients: Breast ...

TimeJuly 28, 2022
arrow
Viz.ai, a leading AI-powered disease detection and intelligent care coordination platform, announced it is partnering with Hyperfine, Inc., creator of the first FDA-cleared point-of-care magnetic resonance imaging (MRI) device, Swoop.
News|Magnetic Resonance Imaging (MRI)

July 27, 2022 — Viz.ai, a leading AI-powered disease detection and intelligent care coordination platform, announced it ...

TimeJuly 27, 2022
arrow
Aidoc artificial intelligence
News|Artificial Intelligence

July 26, 2022 — Aidoc, a leading provider of AI healthcare solutions, today announced a partnership with UofL Health, a ...

TimeJuly 26, 2022
arrow
The Imagio Breast Imaging System helps physicians differentiate between benign and malignant breast lesions using non-invasive opto-acoustic/ultrasound (OA/US) technology to provide information on breast lesions in real time, helping providers to characterize and differentiate masses that may — or may not — require more invasive diagnostic evaluation.
News|2022世界杯篮球预选赛赛程

July 26, 2022 — Seno Medical’s Imagio Breast Imaging System, a revolutionary new modality in breast imaging, has ...

TimeJuly 26, 2022
arrow
The oncology information system market is expected to expand at a 7.8% CAGR. The oncology information system market is expected to grow from $2.59 billion in 2022 to $5.48 billion by 2032
News|Oncology Information Management Systems (OIMS)

July 26, 2022 — The oncology information system market is expected to expand at a 7.8% CAGR. The oncology information ...

TimeJuly 26, 2022
arrow
Subscribe Now